Abstract
WR99210, a dihydrofolate reductase inhibitor, has promising in vitro activity against Mycobacterium avium complex (MAC). The in vitro activities of WR99210 alone and in combination with a fixed concentration of dapsone (0.5 microgram/ml) were evaluated against 35 clinical MAC isolates by a broth dilution method. The MIC at which 50% of isolates were inhibited (MIC50) and MIC90 of WR99210 alone were 2 and 8 micrograms/ml, respectively. The MIC50 and MIC90 of WR99210 in combination with dapsone were 0.25 and 4 micrograms/ml, respectively. Overall, 75% of the MAC isolates displayed enhanced susceptibility to the combination.
Full Text
The Full Text of this article is available as a PDF (162.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chang H. R., Arsenijevic D., Comte R., Polak A., Then R. L., Pechère J. C. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii. Antimicrob Agents Chemother. 1994 Aug;38(8):1803–1807. doi: 10.1128/aac.38.8.1803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edstein M. D., Veenendaal J. R., Rieckmann K. H. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone. Chemotherapy. 1990;36(3):169–176. doi: 10.1159/000238763. [DOI] [PubMed] [Google Scholar]
- Gallant J. E., Moore R. D., Chaisson R. E. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994 Jun 1;120(11):932–944. doi: 10.7326/0003-4819-120-11-199406010-00006. [DOI] [PubMed] [Google Scholar]
- Meyer S. C., Majumder S. K., Cynamon M. H. In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex. Antimicrob Agents Chemother. 1995 Aug;39(8):1862–1863. doi: 10.1128/aac.39.8.1862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seydel J. K. In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria. J Chemother. 1993 Dec;5(6):422–429. [PubMed] [Google Scholar]
- Shepard C. C., McRae D. H., Habas J. A. Sensitivity of Mycobacterium leprae to low levels of 4,4'-diaminodiphenyl sulfone. Proc Soc Exp Biol Med. 1966 Jul;122(3):893–896. doi: 10.3181/00379727-122-31282. [DOI] [PubMed] [Google Scholar]
- Voeller D., Kovacs J., Andrawis V., Chu E., Masur H., Allegra C. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone). J Infect Dis. 1994 Feb;169(2):456–459. doi: 10.1093/infdis/169.2.456. [DOI] [PubMed] [Google Scholar]